Global AI Medicine Software Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03246284

Publication Date:

March 25, 2024

Pages:

133

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global AI Medicine Software market size was valued at US$ million in 2023. With growing demand in downstream market, the AI Medicine Software is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI Medicine Software market. AI Medicine Software are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI Medicine Software. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI Medicine Software market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on AI Medicine Software market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI Medicine Software market. It may include historical data, market segmentation by Type (e.g., Diagnosis Processes, Treatment Protocol Development), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI Medicine Software market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI Medicine Software market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI Medicine Software industry. This include advancements in AI Medicine Software technology, AI Medicine Software new entrants, AI Medicine Software new investment, and other innovations that are shaping the future of AI Medicine Software.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI Medicine Software market. It includes factors influencing customer ' purchasing decisions, preferences for AI Medicine Software product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI Medicine Software market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI Medicine Software market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI Medicine Software market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI Medicine Software industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI Medicine Software market.
Market Segmentation:
AI Medicine Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Diagnosis Processes
Treatment Protocol Development
Drug Development
Personalized Medicine
Patient Monitoring and Care
Segmentation by application
Hospital
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Enlitic
Atomwise
DeepMind
Babylon Health
Flatiron Health
Tempus Labs
Sophia Genetics
Recursion Pharmaceuticals
Synyi
Freenome
GNS Healthcare
Olive
Ada Health
Clarify Health Solutions
Sight Diagnostics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI Medicine Software Market Size 2019-2030
2.1.2 AI Medicine Software Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI Medicine Software Segment by Type
2.2.1 Diagnosis Processes
2.2.2 Treatment Protocol Development
2.2.3 Drug Development
2.2.4 Personalized Medicine
2.2.5 Patient Monitoring and Care
2.3 AI Medicine Software Market Size by Type
2.3.1 AI Medicine Software Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Medicine Software Market Size Market Share by Type (2019-2024)
2.4 AI Medicine Software Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.4.3 Others
2.5 AI Medicine Software Market Size by Application
2.5.1 AI Medicine Software Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Medicine Software Market Size Market Share by Application (2019-2024)
3 AI Medicine Software Market Size by Player
3.1 AI Medicine Software Market Size Market Share by Players
3.1.1 Global AI Medicine Software Revenue by Players (2019-2024)
3.1.2 Global AI Medicine Software Revenue Market Share by Players (2019-2024)
3.2 Global AI Medicine Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI Medicine Software by Regions
4.1 AI Medicine Software Market Size by Regions (2019-2024)
4.2 Americas AI Medicine Software Market Size Growth (2019-2024)
4.3 APAC AI Medicine Software Market Size Growth (2019-2024)
4.4 Europe AI Medicine Software Market Size Growth (2019-2024)
4.5 Middle East & Africa AI Medicine Software Market Size Growth (2019-2024)
5 Americas
5.1 Americas AI Medicine Software Market Size by Country (2019-2024)
5.2 Americas AI Medicine Software Market Size by Type (2019-2024)
5.3 Americas AI Medicine Software Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Medicine Software Market Size by Region (2019-2024)
6.2 APAC AI Medicine Software Market Size by Type (2019-2024)
6.3 APAC AI Medicine Software Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI Medicine Software by Country (2019-2024)
7.2 Europe AI Medicine Software Market Size by Type (2019-2024)
7.3 Europe AI Medicine Software Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI Medicine Software by Region (2019-2024)
8.2 Middle East & Africa AI Medicine Software Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Medicine Software Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI Medicine Software Market Forecast
10.1 Global AI Medicine Software Forecast by Regions (2025-2030)
10.1.1 Global AI Medicine Software Forecast by Regions (2025-2030)
10.1.2 Americas AI Medicine Software Forecast
10.1.3 APAC AI Medicine Software Forecast
10.1.4 Europe AI Medicine Software Forecast
10.1.5 Middle East & Africa AI Medicine Software Forecast
10.2 Americas AI Medicine Software Forecast by Country (2025-2030)
10.2.1 United States AI Medicine Software Market Forecast
10.2.2 Canada AI Medicine Software Market Forecast
10.2.3 Mexico AI Medicine Software Market Forecast
10.2.4 Brazil AI Medicine Software Market Forecast
10.3 APAC AI Medicine Software Forecast by Region (2025-2030)
10.3.1 China AI Medicine Software Market Forecast
10.3.2 Japan AI Medicine Software Market Forecast
10.3.3 Korea AI Medicine Software Market Forecast
10.3.4 Southeast Asia AI Medicine Software Market Forecast
10.3.5 India AI Medicine Software Market Forecast
10.3.6 Australia AI Medicine Software Market Forecast
10.4 Europe AI Medicine Software Forecast by Country (2025-2030)
10.4.1 Germany AI Medicine Software Market Forecast
10.4.2 France AI Medicine Software Market Forecast
10.4.3 UK AI Medicine Software Market Forecast
10.4.4 Italy AI Medicine Software Market Forecast
10.4.5 Russia AI Medicine Software Market Forecast
10.5 Middle East & Africa AI Medicine Software Forecast by Region (2025-2030)
10.5.1 Egypt AI Medicine Software Market Forecast
10.5.2 South Africa AI Medicine Software Market Forecast
10.5.3 Israel AI Medicine Software Market Forecast
10.5.4 Turkey AI Medicine Software Market Forecast
10.5.5 GCC Countries AI Medicine Software Market Forecast
10.6 Global AI Medicine Software Forecast by Type (2025-2030)
10.7 Global AI Medicine Software Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Enlitic
11.1.1 Enlitic Company Information
11.1.2 Enlitic AI Medicine Software Product Offered
11.1.3 Enlitic AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Enlitic Main Business Overview
11.1.5 Enlitic Latest Developments
11.2 Atomwise
11.2.1 Atomwise Company Information
11.2.2 Atomwise AI Medicine Software Product Offered
11.2.3 Atomwise AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Atomwise Main Business Overview
11.2.5 Atomwise Latest Developments
11.3 DeepMind
11.3.1 DeepMind Company Information
11.3.2 DeepMind AI Medicine Software Product Offered
11.3.3 DeepMind AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 DeepMind Main Business Overview
11.3.5 DeepMind Latest Developments
11.4 Babylon Health
11.4.1 Babylon Health Company Information
11.4.2 Babylon Health AI Medicine Software Product Offered
11.4.3 Babylon Health AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Babylon Health Main Business Overview
11.4.5 Babylon Health Latest Developments
11.5 Flatiron Health
11.5.1 Flatiron Health Company Information
11.5.2 Flatiron Health AI Medicine Software Product Offered
11.5.3 Flatiron Health AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Flatiron Health Main Business Overview
11.5.5 Flatiron Health Latest Developments
11.6 Tempus Labs
11.6.1 Tempus Labs Company Information
11.6.2 Tempus Labs AI Medicine Software Product Offered
11.6.3 Tempus Labs AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Tempus Labs Main Business Overview
11.6.5 Tempus Labs Latest Developments
11.7 Sophia Genetics
11.7.1 Sophia Genetics Company Information
11.7.2 Sophia Genetics AI Medicine Software Product Offered
11.7.3 Sophia Genetics AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sophia Genetics Main Business Overview
11.7.5 Sophia Genetics Latest Developments
11.8 Recursion Pharmaceuticals
11.8.1 Recursion Pharmaceuticals Company Information
11.8.2 Recursion Pharmaceuticals AI Medicine Software Product Offered
11.8.3 Recursion Pharmaceuticals AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Recursion Pharmaceuticals Main Business Overview
11.8.5 Recursion Pharmaceuticals Latest Developments
11.9 Synyi
11.9.1 Synyi Company Information
11.9.2 Synyi AI Medicine Software Product Offered
11.9.3 Synyi AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Synyi Main Business Overview
11.9.5 Synyi Latest Developments
11.10 Freenome
11.10.1 Freenome Company Information
11.10.2 Freenome AI Medicine Software Product Offered
11.10.3 Freenome AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Freenome Main Business Overview
11.10.5 Freenome Latest Developments
11.11 GNS Healthcare
11.11.1 GNS Healthcare Company Information
11.11.2 GNS Healthcare AI Medicine Software Product Offered
11.11.3 GNS Healthcare AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GNS Healthcare Main Business Overview
11.11.5 GNS Healthcare Latest Developments
11.12 Olive
11.12.1 Olive Company Information
11.12.2 Olive AI Medicine Software Product Offered
11.12.3 Olive AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Olive Main Business Overview
11.12.5 Olive Latest Developments
11.13 Ada Health
11.13.1 Ada Health Company Information
11.13.2 Ada Health AI Medicine Software Product Offered
11.13.3 Ada Health AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Ada Health Main Business Overview
11.13.5 Ada Health Latest Developments
11.14 Clarify Health Solutions
11.14.1 Clarify Health Solutions Company Information
11.14.2 Clarify Health Solutions AI Medicine Software Product Offered
11.14.3 Clarify Health Solutions AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Clarify Health Solutions Main Business Overview
11.14.5 Clarify Health Solutions Latest Developments
11.15 Sight Diagnostics
11.15.1 Sight Diagnostics Company Information
11.15.2 Sight Diagnostics AI Medicine Software Product Offered
11.15.3 Sight Diagnostics AI Medicine Software Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Sight Diagnostics Main Business Overview
11.15.5 Sight Diagnostics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂